Abstract
Acute respiratory infections (ARI) statistics in Cúcuta, Colombia are reported for each health service or health care providers rather than for residence area. Although official statistics are important sources of data to support evidence-based decisions for at-risk communities, these are of limited use if the geographical distribution of diseases cannot be identified. This study aims to calculate the rate of ARI in each of the Cúcuta’s urban sections using a spatial analysis of the distribution of the HCP.
The spatial scope (geographical area of influence) of the health care providers was established from their spatial distribution and the population accessing their services. Three spatial aggregation levels were established considering the spatial scope of the primary, intermediate and tertiary health care providers. The ARI cases per urban section were calculated according to the spatial distribution of health care providers and the proportion of population, per urban section in each level. A further spatial analysis included the calculation of spatial rates and hotspots of ARI.
There were 97 health care providers providing health services in 31, 20 and 47 urban sections in levels 1, 2 and 3 respectively. A higher spatial rate of ARI was found in urban sections in central south; central west; north and northwest; northeast; central east; and central Cúcuta. Hotspots of higher risk were in clustered in urban sections in central south and west Cúcuta and three isolated urban sections in central and northwest Cúcuta.
The spatial distribution of health services can be used to calculate health indicators at the census district level. This methodology can be used in socioeconomic contexts where geographic identifiers are not attached to health statistics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the ethics committee of the University of Santander, record VII-FT-025-UDES, 021 25/06/2019.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Some typos and grammar issues were identified and corrected in the introduction. Additional clarification on the methodology was added in the methods section. Figures 1 and 2 were updated to include the location of hospitals and GP practices, and the location of public health providers in level 1 and 2 zones. There are no changes in the analysis or the results.
Data Availability
All data produced in the study are available upon reasonable request to the authors. The raw data provided by the Department of Health is subject to their authorisation to be published.
